Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

Chemical methods for the simultaneous quantitation of metabolites and proteins from single cells.

Xue M, Wei W, Su Y, Kim J, Shin YS, Mai WX, Nathanson DA, Heath JR.

J Am Chem Soc. 2015 Apr 1;137(12):4066-9. doi: 10.1021/jacs.5b00944. Epub 2015 Mar 19.

PMID:
25789560
2.

Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke.

Darsalia V, Larsson M, Nathanson D, Klein T, Nyström T, Patrone C.

J Cereb Blood Flow Metab. 2015 May;35(5):718-23. doi: 10.1038/jcbfm.2015.17. Epub 2015 Feb 11.

PMID:
25669907
3.

Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke.

Nathanson D, Patrone C, Nyström T, von Euler M.

Stroke Res Treat. 2014;2014:747458. doi: 10.1155/2014/747458. Epub 2014 Sep 15.

4.

Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization.

Darsalia V, Hua S, Larsson M, Mallard C, Nathanson D, Nyström T, Sjöholm Å, Johansson ME, Patrone C.

PLoS One. 2014 Aug 7;9(8):e103114. doi: 10.1371/journal.pone.0103114. eCollection 2014.

5.

Fracture resistance and failure mode of fatigued endodontically treated teeth restored with fiber-reinforced resin posts and metallic posts in vitro.

A Alharbi F, Nathanson D, Morgano SM, Baba NZ.

Dent Traumatol. 2014 Aug;30(4):317-25. doi: 10.1111/edt.12095. Epub 2014 Feb 7.

PMID:
25039331
6.

Fully automated production of diverse 18F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification.

Lazari M, Collins J, Shen B, Farhoud M, Yeh D, Maraglia B, Chin FT, Nathanson DA, Moore M, van Dam RM.

J Nucl Med Technol. 2014 Sep;42(3):203-10. doi: 10.2967/jnmt.114.140392. Epub 2014 Jul 17.

PMID:
25033883
7.

Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.

Darsalia V, Olverling A, Larsson M, Mansouri S, Nathanson D, Nyström T, Klein T, Sjöholm Å, Patrone C.

Regul Pept. 2014 May;190-191:25-31. doi: 10.1016/j.regpep.2014.05.001. Epub 2014 May 10.

PMID:
24821550
8.

The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia.

Danilova N, Bibikova E, Covey TM, Nathanson D, Dimitrova E, Konto Y, Lindgren A, Glader B, Radu CG, Sakamoto KM, Lin S.

Dis Model Mech. 2014 Jul;7(7):895-905. doi: 10.1242/dmm.015495. Epub 2014 May 8.

9.

GLP-1R activation for the treatment of stroke: updating and future perspectives.

Darsalia V, Nathanson D, Nyström T, Klein T, Sjöholm Å, Patrone C.

Rev Endocr Metab Disord. 2014 Sep;15(3):233-42. doi: 10.1007/s11154-014-9285-9.

PMID:
24777909
10.

Enhanced removal of Enterococcus faecalis biofilms in the root canal using sodium hypochlorite plus photon-induced photoacoustic streaming: an in vitro study.

Al Shahrani M, DiVito E, Hughes CV, Nathanson D, Huang GT.

Photomed Laser Surg. 2014 May;32(5):260-6. doi: 10.1089/pho.2014.3714. Epub 2014 Apr 9. Erratum in: Photomed Laser Surg. 2014 Sep;32(9):524.

11.

Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication.

Nathanson DA, Armijo AL, Tom M, Li Z, Dimitrova E, Austin WR, Nomme J, Campbell DO, Ta L, Le TM, Lee JT, Darvish R, Gordin A, Wei L, Liao HI, Wilks M, Martin C, Sadeghi S, Murphy JM, Boulos N, Phelps ME, Faull KF, Herschman HR, Jung ME, Czernin J, Lavie A, Radu CG.

J Exp Med. 2014 Mar 10;211(3):473-86. doi: 10.1084/jem.20131738. Epub 2014 Feb 24.

12.

Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.

Nathanson DA, Gini B, Mottahedeh J, Visnyei K, Koga T, Gomez G, Eskin A, Hwang K, Wang J, Masui K, Paucar A, Yang H, Ohashi M, Zhu S, Wykosky J, Reed R, Nelson SF, Cloughesy TF, James CD, Rao PN, Kornblum HI, Heath JR, Cavenee WK, Furnari FB, Mischel PS.

Science. 2014 Jan 3;343(6166):72-6. doi: 10.1126/science.1241328. Epub 2013 Dec 5.

13.

The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas.

Gini B, Zanca C, Guo D, Matsutani T, Masui K, Ikegami S, Yang H, Nathanson D, Villa GR, Shackelford D, Zhu S, Tanaka K, Babic I, Akhavan D, Lin K, Assuncao A, Gu Y, Bonetti B, Mortensen DS, Xu S, Raymon HK, Cavenee WK, Furnari FB, James CD, Kroemer G, Heath JR, Hege K, Chopra R, Cloughesy TF, Mischel PS.

Clin Cancer Res. 2013 Oct 15;19(20):5722-32. doi: 10.1158/1078-0432.CCR-13-0527. Epub 2013 Sep 12.

14.

Fast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging system.

Wang J, Hwang K, Braas D, Dooraghi A, Nathanson D, Campbell DO, Gu Y, Sandberg T, Mischel P, Radu C, Chatziioannou AF, Phelps ME, Christofk H, Heath JR.

J Nucl Med. 2013 Oct;54(10):1820-4. doi: 10.2967/jnumed.112.118497. Epub 2013 Aug 26.

15.

Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.

Murphy JM, Armijo AL, Nomme J, Lee CH, Smith QA, Li Z, Campbell DO, Liao HI, Nathanson DA, Austin WR, Lee JT, Darvish R, Wei L, Wang J, Su Y, Damoiseaux R, Sadeghi S, Phelps ME, Herschman HR, Czernin J, Alexandrova AN, Jung ME, Lavie A, Radu CG.

J Med Chem. 2013 Sep 12;56(17):6696-708. doi: 10.1021/jm400457y. Epub 2013 Aug 15.

16.

EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.

Babic I, Anderson ES, Tanaka K, Guo D, Masui K, Li B, Zhu S, Gu Y, Villa GR, Akhavan D, Nathanson D, Gini B, Mareninov S, Li R, Camacho CE, Kurdistani SK, Eskin A, Nelson SF, Yong WH, Cavenee WK, Cloughesy TF, Christofk HR, Black DL, Mischel PS.

Cell Metab. 2013 Jun 4;17(6):1000-8. doi: 10.1016/j.cmet.2013.04.013. Epub 2013 May 23.

17.

Emergency department presentations by Aboriginal children: issues for consideration for appropriate health services.

Duncan C, Williams K, Nathanson D, Thomas S, Cottier C, O'Meara M, Zwi K.

J Paediatr Child Health. 2013 Sep;49(9):E448-50. doi: 10.1111/jpc.12225. Epub 2013 May 21.

PMID:
23692582
18.

Evaluation of the Genisys4, a bench-top preclinical PET scanner.

Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J.

J Nucl Med. 2013 Jul;54(7):1162-7. doi: 10.2967/jnumed.112.114926. Epub 2013 Apr 29.

19.

De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

Akhavan D, Pourzia AL, Nourian AA, Williams KJ, Nathanson D, Babic I, Villa GR, Tanaka K, Nael A, Yang H, Dang J, Vinters HV, Yong WH, Flagg M, Tamanoi F, Sasayama T, James CD, Kornblum HI, Cloughesy TF, Cavenee WK, Bensinger SJ, Mischel PS.

Cancer Discov. 2013 May;3(5):534-47. doi: 10.1158/2159-8290.CD-12-0502. Epub 2013 Mar 26.

20.

PET/CT in Oncology: Current Status and Perspectives.

Czernin J, Allen-Auerbach M, Nathanson D, Herrmann K.

Curr Radiol Rep. 2013 May 3;1:177-190. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk